Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Cancelled
  • ACRO 2022 Scientific Planning Committee
  • SEAL Faculty
  • Cancelled
  • #Brachytherapy: Physicians as Influencers on Instagram
  • A Dosimetric Comparison of Intensity Modulated Radiation Therapy and Intensity Modulated Proton Therapy Accelerated Partial Breast Irradiation with Emphasis on Left Anterior Descending Coronary Artery Doses
  • Adrenal Stereotactic Body Radiation Therapy in the Management of Oligometastatic Lung Cancer: Patient Selection Matters
  • An Analysis of Risk Factors for Cerebral Radiation Necrosis Following Stereotactic Radiosurgery
  • Analysis of Adjuvant Vaginal Cylinder Brachytherapy for Endometrial Cancer: Recurrence Outcomes for Stage I and II Disease
  • Assessment of Gastrointestinal Luminal Air Effects on Dose Calculation Accuracy for Pancreatic Cancer Stereotactic MR-guided Adaptive Radiation Therapy
  • Bone Marrow Sparing Volume Modulated Arc Therapy in Whole Lung Irradiation
  • Cancer Diagnoses and Use of Radiation Therapy Among Patients Experiencing Homelessness
  • Clinical Implementation of TG-203 in a High Risk CIED Patient
  • Clinical Outcomes with Varying Proton Craniospinal Irradiation Practices: A Pediatric Proton Consortium Registry (PPCR) Study
  • Clinical validation of a workflow interfacing radiation oncology lung stereotactic body radiotherapy treatment planning and diagnostic radiology
  • Comparison of clinical monocyte count between radiotherapy fractionation schemes for glioblastoma
  • Concurrent immunoradiation is associated with inferior survival as compared to chemoradiation for HPV-Associated Oropharyngeal Squamous Cell Carcinomas
  • Correlation between Decipher® neuroendocrine signatures and histopathological features of neuroendocrine cancer of the prostate
  • Cost Analysis of a Hybrid Applicator Compared to Syed Template-Based Interstitial Brachytherapy for Gynecologic Malignancies
  • Definitive radiation therapy with or without chemotherapy for vulvar cancer with positive sentinel lymph node
  • Development of an Educational Mobile Application for Patients Undergoing Radiation Therapy: Results of a Pilot Study to Understand Patient and Physician Needs
  • Development of an Updated Peer Review Process to Facilitate Communication and Improve Plan Quality and Safety
  • Dosimetric Analysis of Cardiac Toxicity after Breast Radiotherapy
  • Efficacy and safety of stereotactic body radiation therapy (SBRT) for pediatric malignancies
  • Elderly adults with cancer and the potential role of Medicaid expansion
  • Fifteen Year Experience with Accelerated Partial Breast Irradiation at a Community Cancer Center
  • Genome wide interrogation of somatic mutational signatures of oxidative stress and driver mutations in mouse and human cancers
  • Harnessing Cerium Oxide Nanoparticles Combined with Tolfenamic Acid to Sensitize Head and Neck Cancer to Radiation
  • High Local Control and Under-Reported Ophthalmologic Toxicity Using “Boom-Boom” Radiation Therapy for Indolent Orbital Lymphoma
  • HPV E7-specific Soluble T-cell Receptor Radiopharmaceutical Therapy
  • Hypofractionated intensity modulated proton therapy (IMPT) and systemic therapy for unresectable hepatobiliary cancers
  • Identifying Predictors of Success in Contouring Education Among Radiation Oncology Trainees
  • Impact of Consolidative Therapies After Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Database Analysis
  • Impact of Individualized Patient Education Material on Patients’ Cancer Care Experiences
  • Impact of Routine Surveillance Imaging on Detecting Recurrence in Sinonasal Malignancies
  • Initial Experience of Adaptive Radiation Therapy for Patients with Early Stage Prostate Cancer Treated on the Ethos Unit
  • Is it Non-Hodgkin’s lymphoma or tubercular lymphadenitis: A diagnostic dilemma
  • Knockdown of Rad51 expression induces radiosensitivity of gastrointestinal stromal tumor cells
  • Loss of Protein Kinase R increases cell-intrinsic radiosensitivity of B16 melanoma cells
  • Low-Dose Total Skin Electron Beam Therapy Using the Modified Stanford Technique: An In-Vivo Dosimetry Confirmation Study
  • Margin status after pre-operative radiation for borderline resectable pancreatic cancer
  • Mismatch repair status and recurrence in endometrial cancer: Prognostic implications
  • Mitochondrial DNA mutational burden is associated with negative prognostic outcome in a spectrum of malignancies
  • Morbidity and mortality following pancreas SBRT
  • Multi-parametric MRI Guided Dose-Escalated Radiotherapy For Localized Prostate Cancer: A Prospective Phase II Trial
  • Neddylation modification antagonizes ubiquitylation and degradation of LSD1 to promote radiation resistance of lung cancer cells
  • Olfactory Perception During Proton Radiation and Differences in Frequency of Olfactory Perceptions Based on Proton Craniospinal Irradiation Technique for Pediatric Brain Tumor Patients
  • Outcomes of Hepatocellular Carcinoma Treated with Liver SBRT
  • Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT): A Pilot Study of Consolidated Simulation and Target Identification of Quad Shot Radiation Using an Adaptive Radiotherapy Workflow
  • Patterns of Care and Outcomes in Management of Localized High Grade Neuroendocrine Carcinoma of the Anal Canal
  • Patterns of Care and Outcomes of Early Stage I-II Hodgkin Lymphoma Treated with or without Radiation Therapy
  • Patterns of failure for patients with large, node-negative non-small cell lung cancer treated with definitive radiation reveals high rates of regional and distant failure
  • Phase Ⅰ Trail of Concurrent Nab-paclitaxel and Cisplatin with radiotherapy for locally advanced cervical cancer
  • Prognostic Impact of Radiation Therapy in Stage I Nodal Marginal Zone Lymphoma
  • Proof-of-principle approach for analysis of radiomic features in patients with ultracentral and central lung lesions treated using MR-guided hypofractionated radiotherapy
  • Prostate-specific antigen (PSA) control following focal low-dose-rate brachytherapy for hemi-gland prostate cancer with Cesium-131
  • Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for Junior Faculty: 1-Year Results of a Prospective Single Institution Initiative
  • Radiotherapy Deserts and the Radiation Oncology Alternative Payment Model: Risk to and Underrepresentation of Regions with Increased Palliative Need in Late-Stage Prostate Cancer
  • Rapid Early Progression in Glioblastoma Patients: Missing the Target
  • Reducing Radiation Oncology Package Time and Key Elements for its Optimization
  • Re-irradiation of recurrent head and neck cancers using pulsed reduced dose-rate radiotherapy: an institutional series
  • Risk of contralateral failure following ipsilateral neck irradiation for tonsil cancer – a systematic review and meta-analysis of 1,487 patients
  • Standardizing Physician Chart Rounds to Improve Error Detection in Radiation Oncology
  • Stereotactic body and hypo-fractionated radiotherapy treatment time for thoracic tumors with MRI-guided radiotherapy
  • Stereotactic Body Radiation Therapy for Prostate Cancer After Radical Prostatectomy: First Toxicity Results of a Prospective Single-Arm Phase 2 Trial (SCIMITAR)
  • Stereotactic Body Radiotherapy Boost for Advanced Stage Non-Operable Non-Small Cell Lung Cancer
  • Stereotactic MR-guided Adaptive Radiotherapy (SMART): Initial Single Institution Experience using an Adapt-To-Shape (ATS) Workflow for Abdominal SBRT
  • Thermoplastic mask-induced contact dermatitis: a case report
  • Time-Restricted Eating in Locally Advanced Rectal Cancer: a multi-site, randomized clinical trial of a dietary intervention
  • Transitioning to virtual conferences: the impact on carbon emissions
  • Trends in Diagnoses of Non-Infectious Pneumonitis in Medicare Patients with Advanced Non-Small Cell Lung Cancer
  • Unilateral neck treatment with either surgery or radiotherapy for squamous cell carcinoma of the tonsil
  • Updated Outcomes and Evolving Treatment Paradigms for Small Cell Carcinoma of the Bladder
  • Utilization of an MR-Linac adapted composite plan for dosimetric analysis in patients receiving MR-Linac guided SBRT
  • Utilization of stereotactic body radiation therapy and circulating tumor DNA analysis to guide adjuvant systemic therapy in the setting of patients with oligometastatic disease
  • Variants of squamous cell carcinoma of the breast: Should they be a unique entity?
  • YouTube as a Source of Information on Radiation Therapy
  • Wednesday, March 9, 2022
  • 2:00 PM – 5:00 PM US EST
    Coding
  • 7:00 PM – 9:00 PM US EST
    Welcome Reception
  • Thursday, March 10, 2022
  • 7:30 AM – 8:30 AM US EST
    Breakfast with Exhibitors
  • 7:30 AM – 8:30 AM US EST
    Novocure Symposium
  • 8:30 AM – 8:35 AM US EST
    Welcome from the President
  • 8:35 AM – 9:35 AM US EST
    Keynote Address

    *Speaker: Walter Curran, MD – GenesisCare

    Physicians

    SEAL

    Residents

    1 CME

  • 9:35 AM – 10:35 AM US EST
    General Session
  • 10:35 AM – 10:55 AM US EST
    Refreshment Break with Exhibitors
  • 10:55 AM – 11:55 AM US EST
    LUNG: The Quest to Improve Long-Term Survival for Lung Cancer

    Moderator: Stephen Chun, MD – MD Anderson Cancer Center

    *Moderator: Lisa Singer, MD PhD – University of California, San Francisco

    Physicians

    Residents

    1 CME, 1 SAM

  • 11:00 AM – 11:15 AM US EST
    SEAL Welcome
  • 11:15 AM – 12:15 PM US EST
    SEAL Leadership

    SEAL

  • 12:00 PM – 1:00 PM US EST
    Blue Earth Symposium
  • 12:00 PM – 1:00 PM US EST
    Diversity and Inclusion Reception
  • 12:00 PM – 1:00 PM US EST
    Lunch with Exhibitors
  • 12:30 PM – 1:15 PM US EST
    SEAL Lunch
  • 1:05 PM – 2:05 PM US EST
    ECONTOUR: Lung Econtouring: Navigating the Ever-Growing Complexity of Lung Treatment Planning

    Moderator: Jessica M. Schuster, MD – University of Wisconsin School of Medicine and Public Health and Middleton Veteran Affairs Hospital

    Moderator: Tristram Arscott, MD – Compass Oncology

    Physicians

    Residents

    1 CME, 1 SAM

  • 1:15 PM – 2:45 PM US EST
    SEAL Staff Engagement

    SEAL

  • 2:05 PM – 3:05 PM US EST
    BRAIN: Primary Brain Tumors: From Grade School to Gray Hair

    Moderator: Jerry Jaboin, MD, PhD, MBA – University of Oklahoma Health Sciences Center

    Moderator: Albert Attia, MD – Bon Secours Mercy Health

    Physicians

    Residents

    1 CME, 1 SAM

  • 2:45 PM – 3:15 PM US EST
    Refreshment Break with Exhibitors
  • 3:10 PM – 4:10 PM US EST
    New Practitioner Symposium

    *Moderator: Brandon R. Mancini, MD, MBA – West Michigan Cancer Center

    *Moderator: Alexander Harris, MD – Radiation Oncology Consultants Ltd.

    *Moderator: Jenna Kahn, MD – Oregon Health Sciences University

    Panelist: Tarita Thomas, MD, PhD, MBA – Northwestern University

    Panelist: Randy Kahn

    Panelist: Thomas Klein

    Panelist: Anna Olson

    Physicians

  • 3:10 PM – 4:10 PM US EST
    Refreshment Break with Exhibitors
  • 3:10 PM – 4:10 PM US EST
    Varian Symposium
  • 3:15 PM – 3:20 PM US EST
    Introduction to the ACRO Pathways Project
  • 3:15 PM – 4:15 PM US EST
    SEAL Quality
  • 3:15 PM – 4:30 PM US EST
    SEAL Quality #1

    SEAL

  • 4:15 PM – 4:30 PM US EST
    Accreditation Q&A
  • 4:15 PM – 5:15 PM US EST
    BREAST: The Twin Sisters of Breast Cancer Radiotherapy: Timing and Aesthetics

    Moderator: Sushil Beriwal, n/a – Allegheny General Hospital

    Physicians

    Residents

    1 CME, 1 SAM

  • 5:15 PM – 6:15 PM US EST
    AstraZeneca Symposium
  • 5:15 PM – 6:15 PM US EST
    Oral Presentations of Abstracts
  • 6:15 PM – 7:15 PM US EST
    Quick Pitch Posters with Professors
  • Friday, March 11, 2022
  • 7:00 AM – 8:00 AM US EST
    Breakfast with Exhibitors
  • 7:00 AM – 8:00 AM US EST
    Vision RT Symposium
  • 8:05 AM – 9:05 AM US EST
    ADVANCED MODALITIES: Emerging Technologies in Radiation Oncology: Clinical Applications and Practical Considerations

    Moderator: Isabelle Choi, MD – New York Proton Center

    *Moderator: Shannon MacDonald, MD – Massachusetts General Hospital

    Physicians

    Residents

    1 CME, 1 SAM

  • 8:30 AM – 9:30 AM US EST
    SEAL Quality #2

    SEAL

  • 8:30 AM – 9:30 AM US EST
    SEAL Quality
  • 9:05 AM – 9:10 AM US EST
    Introduction to the ACRO Pathways Project
  • 9:05 AM – 10:15 AM US EST
    GU: Today on SPPORTsCenter!: An update on RTOG 0534 and Treatment of Prostate Cancer with SABR

    Moderator: Michael Bernstein, MD – Memorial Sloan Kettering Cancer Center

    Moderator: Dayssy Alexandra Diaz Pardo, MD, MS – The Ohio State University

    Physicians

    Residents

    1 CME, 1 SAM

  • 9:30 AM – 10:00 AM US EST
    Refreshment Break with Exhibitors
  • 10:00 AM – 11:30 AM US EST
    SEAL Patient Experience & Nursing

    SEAL

  • 10:00 AM – 11:30 AM US EST
    SEAL Patient Experience
  • 10:10 AM – 10:50 AM US EST
    Refreshment Break with Exhibitors
  • 10:50 AM – 11:50 AM US EST
    GYN: Optimizing Care for Gynecological Cancer Through Genomics and Technology

    Moderator: Emma C. Fields, MD – VCU School of Medicine

    Moderator: Jill Remick, MD – Emory University

    Physicians

    Residents

    1 CME, 1 SAM

  • 12:00 PM – 1:00 PM US EST
    Dr. Sucha Asbell Women's Forum
  • 12:00 PM – 1:00 PM US EST
    Poster Walk with Professors
  • 12:00 PM – 1:00 PM US EST
    SEAL Lunch
  • 1:00 PM – 2:30 PM US EST
    SEAL Operations & Strategy

    SEAL

  • 1:00 PM – 2:30 PM US EST
    SEAL Strategy
  • 1:05 PM – 2:05 PM US EST
    HEAD/NECK: Management of Potentially Virally-Mediated Malignancies of the Head and Neck

    *Moderator: Anna Lee, MD, MPH – University of Texas MD Anderson Cancer Center

    *Moderator: Heath Skinner, MD, PhD – UPMC Hillman Cancer Center and the University of Pittsburgh

    Physicians

    Residents

    1 CME, 1 SAM

  • 2:05 PM – 3:00 PM US EST
    Luther Brady Lecture
  • 2:45 PM – 3:45 PM US EST
    SEAL Billing & Value

    SEAL

  • 2:45 PM – 3:45 PM US EST
    SEAL Operations & Strategy
  • 3:00 PM – 3:30 PM US EST
    Awards Ceremony
  • 3:30 PM – 3:45 PM US EST
    ACRO Accreditation Update
  • 3:30 PM – 5:00 PM US EST
    Residents and New Practitioners – “Challenging Cases”
  • 3:45 PM – 4:00 PM US EST
    SEAL Wrap-Up
  • 3:45 PM – 4:30 PM US EST
    ACRO Advocacy and PAC Leadership – For You and By You
  • 3:45 PM – 5:00 PM US EST
    Standards Committee Meeting
  • 5:00 PM – 6:25 PM US EST
    ACRO Happy Hour & Quizzo
  • 6:30 PM – 7:30 PM US EST
    President’s Reception
  • Saturday, March 12, 2022
  • 7:00 AM – 7:30 AM US EST
    Finance & Operations Committee
  • 7:00 AM – 7:45 AM US EST
    New Practitioners Committee Meeting
  • 7:00 AM – 8:00 AM US EST
    Membership Committee
  • 7:30 AM – 9:00 AM US EST
    Continental Breakfast
  • 8:00 AM – 9:00 AM US EST
    Lantheus Medical Symposium
  • 8:15 AM – 9:00 AM US EST
    PAC Meet & Greet with Congressman Gus Bilirakis
  • 9:10 AM – 10:10 AM US EST
    GI: Making Moves in GI – Updating Your Practice in Esophageal and Rectal Cancers

    Moderator: David T. Marshall, MD, MS – Hollings Cancer Center, Medical University of South Carolina

    Moderator: Thomas Kim, MD – Rush Medical College

    Physicians

    Residents

    1 CME, 1 SAM

  • 10:10 AM – 11:10 AM US EST
    Oligometastatic Disease: A Look Back and Ablating a Path Forward

    Moderator: Charles B. Simone, II, MD – New York Proton Center

    Moderator: Michael Bernstein, MD – Memorial Sloan Kettering Cancer Center

    Physicians

    Residents

    1 CME, 1 SAM

  • 11:10 AM – 1:00 PM US EST
    Resident and New Practitioner Meetings